Okami Medical
Aliso Viejo, US · Founded 2014 · Delaware corporation · 3 known investors
Okami Medical develops the LOBO vascular occlusion system, an occluder built on high-density, small-pore HDBRAID technology for fast arterial occlusion in the peripheral vasculature, along with SENDERO microcatheters and delivery catheters. Its products are intended for physicians treating peripheral vascular conditions.
BiotechHardwareHealthtechMedical Devices
Founders & leadership
Okami Medical was founded in 2014 by Brian J. Cox.
BJ
Brian J. CoxManager
RR
Rhonda RobbExecutive
RR
Robert RosenbluthNamed on SEC filing
Board
DM
Donald MilderBoard director
JR
PL
Paul LubockBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$77.2M disclosed across 8 rounds · 2016–2025
▶$28.9MraisedDec 2025 · 27 investors · Other TechnologyRule 506(b)
▶$28.9MraisedDec 2025 · 27 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Robert RosenbluthDirector
- Jonathan RootDirector
- Donald MilderDirector
- Mike KramerDirector
- William HoffmanDirector
- Andrew HykesExecutive Officer, Director
- Kirk NielsenDirector
- Paul LubockDirector
- Offering amount
- $46.7M
- Amount sold
- $28.9M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.6MraisedSep 2024 · 8 investors · Other TechnologyRule 506(b)
▶$18.6MraisedSep 2024 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Rhonda RobbExecutive Officer, Director
- Donald MilderDirector
- Robert RosenbluthDirector
- Paul LubockDirector
- Jonathan RootDirector
- Offering amount
- $30M
- Amount sold
- $18.6M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedJan 2024 · 20 investors · Other TechnologyRule 506(b)
▶$5.7MraisedJan 2024 · 20 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan RootDirector
- Brian CoxDirector
- Paul LubockDirector
- Robert RosenbluthExecutive Officer, Director
- Donald MilderDirector
- Offering amount
- $6.1M
- Amount sold
- $5.7M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedSep 2021 · 19 investors · Other TechnologyRule 506(b)
▶$7.5MraisedSep 2021 · 19 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brian CoxDirector
- Jonathan RootDirector
- Robert RosenbluthExecutive Officer, Director
- Paul LubockDirector
- Donald MilderDirector
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.2MraisedJun 2020 · 18 investors · Other TechnologyRule 506(b)
▶$7.2MraisedJun 2020 · 18 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Donald MilderDirector
- Jonathan RootDirector
- Robert RosenbluthExecutive Officer, Director
- Brian CoxDirector
- Paul LubockDirector
- Offering amount
- $7.2M
- Amount sold
- $7.2M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedApr 2019 · 18 investors · Other TechnologyRule 506(b)
▶$3MraisedApr 2019 · 18 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan RootDirector
- Donald MilderDirector
- Paul LubockDirector
- Brian CoxDirector
- Robert RosenbluthExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4.5MraisedAug 2017 · 18 investors · BiotechnologyRule 506(b)
▶$4.5MraisedAug 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert RosenbluthExecutive Officer
- Brian J. CoxExecutive Officer
- Paul LubockExecutive Officer
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Jun 2017
- Incorporated
- Limited Liability Company, Delaware, 2017
- Federal exemptions
- 06b
▶$1.6MraisedMay 2016 · 14 investors · BiotechnologyRule 506(b)
▶$1.6MraisedMay 2016 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian J. CoxExecutive Officer
- Paul LubockExecutive Officer
- Robert RosenbluthExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- May 2016
- Incorporated
- Limited Liability Company, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapMassdevice11 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Innova Vascular9 shared keywordsInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Merit Medical6 shared keywordsMerit Medical Systems designs, develops, manufactures and markets medical devices for interventional and diagnostic procedures. The company serves healthcare providers and clinical practitioners in the medical device industry.
Rf Surgical6 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies competing with Okami Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Okami Medical do?
- Okami Medical develops the LOBO vascular occlusion system, an occluder built on high-density, small-pore HDBRAID technology for fast arterial occlusion in the peripheral vasculature, along with SENDERO microcatheters and delivery catheters. Its products are intended for physicians treating peripheral vascular conditions.
- Who founded Okami Medical?
- Okami Medical was founded by Brian J. Cox in 2014.
- Who are Okami Medical's investors?
- Okami Medical's investors include US Venture Partners, Gilde Healthcare, Vensana Capital.
- How much funding has Okami Medical raised?
- Okami Medical has disclosed $77.2M raised across 8 rounds.
- Where is Okami Medical headquartered?
- Okami Medical is headquartered in Aliso Viejo, US.